Effects of lactic acid bacteria-fermented dandelion Jiangshui on blood glucose levels in hyperglycemic mice

Fermented dandelion Jiangshui reduced several signs of metabolic stress in hyperglycemic mice, but human evidence is still absent.

Source: Frontiers in Microbiology, by Xian-Gang Meng; Jia-ni Lu; Hui Yao; Qing-kai Jin; Yi-xin Zhang; Zhi-hui Wang; Tuan-Jie Che; Yan-Wen Gui. AI-generated summary by biochip.com, published . Not independently reviewed.

Key takeaways

  • In 45 hyperglycemic mice, 14 weeks of fermented dandelion Jiangshui attenuated blood glucose increases versus the model group.
  • Treated mice had higher IL-10 and liver antioxidant enzyme activity, lower MDA, and less severe pancreatic and renal lesions.
  • The study was limited to mice and provides no human safety, dosing, or clinical effectiveness data.

A study in hyperglycemic mice found that a fermented drink made from dandelion, called Jiangshui, was associated with slower rises in blood glucose and less tissue damage in the pancreas and kidneys. The researchers fermented dandelion with three strains of lactic acid bacteria, microbes commonly used to make fermented foods, then gave the resulting preparation to mice for 14 weeks. Compared with untreated hyperglycemic mice, the treated group had higher levels of IL-10, a signaling protein that can help restrain inflammation. They also showed stronger activity of antioxidant enzymes in the liver and lower levels of malondialdehyde, a marker linked to oxidative damage. Microscopic examination suggested that pancreatic and kidney lesions were less severe in mice receiving the fermented dandelion preparation. The work builds on prior interest in Taraxacum mongolicum, a dandelion species rich in dietary fiber that has been reported to have glucose-lowering activity. Still, this was an animal experiment, not a clinical trial, so it does not establish that fermented dandelion Jiangshui can treat high blood glucose in people.

A traditional fermented food under study

Jiangshui is a traditional fermented food or beverage, and the researchers used dandelion as its plant ingredient. Rather than relying on microbes already present in the raw material, the team inoculated the dandelion preparation with selected bacterial strains that they had previously isolated from traditional Jiangshui.

The strains were Lactiplantibacillus plantarum A1 and Lacticaseibacillus paracasei A3 and L2. Lactic acid bacteria turn sugars into lactic acid during fermentation, much as they do in yogurt, kimchi, and sauerkraut. That process can change a food's chemistry, potentially affecting compounds from the plant and creating new microbial metabolites.

How the mouse experiment worked

The researchers enrolled 45 male C57BL/6 mice that were five weeks old and randomly assigned them to three groups: a normal control group, a hyperglycemic model group, and a Jiangshui intervention group. Hyperglycemia means abnormally high blood glucose, the defining metabolic problem in diabetes.

For 14 consecutive weeks, mice in the intervention group received lactic acid bacteria-fermented dandelion Jiangshui by gavage, a technique that delivers a measured liquid dose directly into the stomach through a small tube. The normal and model groups received the same volume of normal saline instead. The researchers tracked body weight and glucose-related biochemical indicators, then examined pancreatic and kidney tissue under the microscope.

Blood glucose rose less sharply

The central result was not that Jiangshui eliminated hyperglycemia, but that it attenuated increases in blood glucose compared with the model group. In plain terms, blood glucose still needed to be monitored in the experimental setting, but the treated mice showed a less severe upward trend than hyperglycemic mice that received saline.

That distinction matters. A lower or slower rise in blood glucose in a mouse model is an early biological signal, not proof of a treatment effect in people. The supplied study summary does not report the numerical glucose values, the exact model used to induce hyperglycemia, or whether the fermented product was compared with unfermented dandelion.

Inflammation and oxidative stress moved in a favorable direction

The Jiangshui group had higher levels of interleukin-10, or IL-10. Cytokines are proteins cells use to send immune messages, and IL-10 is commonly described as anti-inflammatory because it can limit overly aggressive inflammatory responses.

The researchers also measured several antioxidant enzymes in the liver: glutathione peroxidase, superoxide dismutase, and catalase. These enzymes function a little like a cleanup crew, helping neutralize chemically reactive molecules before they damage cells. Activity of all three enzymes increased in the Jiangshui group relative to the model group, while malondialdehyde, often abbreviated MDA, decreased.

MDA is produced when oxidative reactions damage fats in cell membranes, so lower levels can be consistent with reduced oxidative stress. But these biochemical markers do not by themselves identify which compounds in dandelion Jiangshui caused the changes. They also cannot tell whether the bacterial strains, dandelion components, fermentation products, or their combination played the decisive role.

Pancreas and kidneys showed fewer lesions

High blood glucose can place stress on several organs, including the pancreas, which produces insulin, and the kidneys, which filter blood and regulate fluid balance. The study reports that pancreatic and renal lesions were less severe in the mice given fermented dandelion Jiangshui than in untreated hyperglycemic mice.

This tissue evidence is important because it links the blood and biochemical measurements to organs vulnerable to metabolic disease. Yet histopathology, the microscopic examination of diseased tissue, shows structural changes rather than a complete explanation of cause and effect. The summary does not provide lesion scores, images, or detailed descriptions of the specific cellular changes observed.

Why fermentation could change the outcome

Fermentation is not simply a preservation step. Think of the bacteria as tiny food processors: they consume available nutrients and leave behind a changed mixture of acids and other metabolites. In a plant-based preparation, that activity may alter the availability or behavior of naturally occurring compounds.

The study was designed to test the finished fermented Jiangshui product, not to isolate a single active ingredient. That is useful for evaluating the traditional-style preparation as consumed in the experiment, but it leaves open a practical question: which part of the formula is responsible for the observed effects? Future experiments could compare fermented and unfermented dandelion, test individual bacterial strains, and measure the product's chemical composition.

Why This Matters

Diabetes-related research needs approaches that address more than a single glucose reading. Persistent hyperglycemia is connected to inflammation, oxidative stress, and damage in organs such as the kidney, so the study's combination of blood, enzyme, immune, and tissue measurements offers a broader view of what changed in these mice.

At the same time, the evidence remains preliminary. The study involved 45 young male mice, used a 14-week intervention, and did not establish safety, dose, taste, manufacturing consistency, or effectiveness in humans. Animal findings can guide hypotheses, but human metabolism, diet, gut microbes, and disease progression are much more variable.

The next useful step would be carefully designed studies that report the product's composition, clarify its active components, and test whether similar effects appear in other animal models and eventually in people. Until then, fermented dandelion Jiangshui should be viewed as an experimental dietary preparation with promising signals in hyperglycemic mice, not as a validated therapy for diabetes.